4 ms·
Does anyone know why this vaccine "only requires one dose"? Is the number of doses just an arbitrary decision by the manufacturers, or is it determined by the
by BurningFrog 6y ago
Does anyone know why this vaccine "only requires one dose"?
Is the number of doses just an arbitrary decision by the manufacturers, or is it determined by the technology somehow?
- valarauko 6y agoOne takeway from the Pfizer & Moderna trials was that a single dose of those vaccines were also fairly protective for most people. With those vaccines, if you could avoid being infected within two weeks of the first dose, it looks like the protection is ~ 90% against COVID. The second dose acts as a booster, and with J&J, a second dose does indeed increase the antibody titre about three fold. That said, a single dose of any of these vaccines is probably "good enough". Couple of caveats: With Pfizer & Moderna, the major difference in outcome for single dose participants was a reduced protection from 'severe COVID', down to about 50%. It's also a very small group (~1000 people), so there's the risk of over interpreting the results. The other thing to consider is that a second dose might be required for older adults, who have a reduced immune response from a single dose.
- maxerickson 6y agoIt's not arbitrary, but it's part of the design of the Phase 3 trial. One of the goals of the Phase 1 trial is to figure out the dosing, both the size and whether there is a booster needed and so on. J&J has started a trial to evaluate adding a second dose. And of course there's lots of talk about delaying the 2nd doses of the other vaccines. It's likely enough they could have been approved as single dose vaccines. It'd be fascinating to have some insight into the conversations they had while deciding what dosing to trial.
- BurningFrog 6y ago> It's not arbitrary, but it's part of the design of the Phase 3 trial. What I'm trying to understand is if there is any inherent difference that makes one vaccine suitable for one dose and another for two doses. I still haven't seen anything answering this.
- maxerickson 6y agoThey try to work out the immune response in Phase I, and then use that protocol for II and III. I wrote the bit you quote because it gets determined before the efficacy trial. So it isn't arbitrary because they use data to work it out, and then it is sort of fixed once the later phases begin. Given more money and so on they could probably do multiple simultaneous studies. With Covid, a trade-off there would be splitting up the enrollment and slowing down the results. 2 doses triggers a larger immune response, so it is one way to increase the likelihood that the studied dosing is found to be efficacious. And then they are also factoring in other understanding of the immune system, it won't just be about "more is better".
- BurningFrog 6y agoOh, I see: You're saying they use data from Phase 1 to try to infer how many doses would be best. That does make sense, but it must be pretty far from an "exact science". To my (rather recent) understanding, all vaccines benefit from a booster dose. Because that's how the human immune system works.
- CyberDildonics 6y agoDo you actually believe the number of doses would be an arbitrary decision? The effectiveness has been tested at different intervals after each dose. The manufacturing and logistics change dramatically when there is more than one dose. If one dose was needed the vaccinations could be mostly done in spring instead of through the summer. I can't believe anyone would actually think something so crucial would be chosen arbitrarily or on a whim.